🇺🇸 FDA
Patent

US 6521635

Inhibition of MXR transport by acridine derivatives

expired A61KA61K31/4545A61K45/06

Quick answer

US patent 6521635 (Inhibition of MXR transport by acridine derivatives) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4545, A61K45/06